Preliminary Study Leading to Prevention of Pressure Ulcers by the Use of an On-board Device : Ergonomic Assessment of Wheelchair-seat Pressures in Spinal Cord Injured (SCI) Patients ( PRESDIE)

NCT ID: NCT01834417

Last Updated: 2020-02-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-18

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Analysis of stored seat-pressures in SCI patients during a 4-week use of an on-board device. During this period, patients write in an agenda noteworthy events that could occur while they're using their wheelchair. A control is done every week and the device can be changed until it is returned at the end of the study period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* inclusion visit : recovery of the signed informed-consent form, clinical examination, skin control, seat-pressures control, device 9-position control, delivery of the agenda for noteworthy events
* 3 follow-up visits : noteworthy events check, skin control, cushioncloth control, device 9-position control
* return visit : device return, agenda return, skin control, seat-pressures control

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pressure Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TexiMat

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is male or female, aged ≥ 18
* Patient accepting the initial assessment and the following visits during the protocol
* Written informed consent has been obtained
* Patient having a social assurance
* Spinal cord injury ≤ C6 stable Spinal cord trauma \> 1 an
* Main mode of ambulation : own manual wheelchair

Exclusion Criteria

* Aged ≤ 18
* Adults under guardianship
* Patients do not speak French, refusing or unable to be followed
* Pregnant or lactating women
* Person deprived of their liberty by judicial or administrative decision
* Person hospitalised without consent
* Pelvic pressure ulcer ongoing
* Cognitive disorder incompatible with the use of the device, understanding and conduct of the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brigitte PERROUIN-VERBE, PU-PH

Role: PRINCIPAL_INVESTIGATOR

CHU de Nantes- Hôpital Saint Jacques

Marc Le Fort, PH

Role: STUDY_CHAIR

CHU de Nantes-Hôpital Saint Jacques

Guy Egon

Role: STUDY_CHAIR

Centre de l'Arche

Djamel Bensmail, PU-PH

Role: STUDY_CHAIR

CH Raymond Poincaré

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Nantes

Nantes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC11_0009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pressure Ulcer Prevention Study in SCI
NCT01999816 COMPLETED PHASE3
Low Friction Bed Sheet
NCT01943201 COMPLETED NA